Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Catalyst Biosciences Inc

CBIO
Current price
23.31 USD -2.72 USD (-10.45%)
Last closed
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 19 418 204 USD
Yield for 12 month +4 239.17 %
Week
Month
Year
CBIO
21.11.2021 - 28.11.2021

Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of liver fibrosis associated with a broad spectrum of chronic liver diseases in the United States and internationally. It develops Hydronidone, that has completed phase 1 clinical trial for the treatment of nonalcoholic steatohepatitis, a severe form of nonalcoholic fatty liver disease. The company was founded in 2002 and is headquartered in South San Francisco, California. Address: 611 Gateway Boulevard, South San Francisco, CA, United States, 94080

Analytics

WallStreet Target Price

16 USD

P/E ratio

Dividend Yield

792.92 %

Current Year

+794 000 USD

Last Year

+7 338 000 USD

Current Quarter

Last Quarter

Current Year

-4 000 USD

Last Year

-42 000 USD

Current Quarter

Last Quarter

Key Figures CBIO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -13 524 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -41.29 %
PEG Ratio 0.02
Return On Equity TTM -269.01 %
Wall Street Target Price 16 USD
Revenue TTM
Book Value -11.77 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -100 %
Dividend Yield 792.92 %
Gross Profit TTM -64 906 000 USD
Earnings Share -20.7 USD
Diluted Eps TTM -20.7 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics CBIO

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CBIO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 15.94
Ex Dividend Date 13.01.2023
Forward Annual Dividend Yield 792.92 %
Last Split Factor 1:15
Payout Ratio
Last Split Date 13.02.2017
Dividend Date 12.01.2023

Stock Valuation CBIO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 4.9752
Price Sales TTM 4.8219
Enterprise Value EBITDA -0.5915
Price Book MRQ 0.5274

Financials CBIO

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators CBIO

For 52 weeks

2.83 USD 11.1 USD
50 Day MA 0.64 USD
Shares Short Prior Month 71 894
200 Day MA 0.37 USD
Short Ratio 0.19
Shares Short 34 049
Short Percent 0.11 %